Long Acting Injection Prevents Women From HIV Infection

Researchers have discovered that injection of a long-lasting injection called cabotegravir, every 2 months is 89% more effective than Truvada pills in reducing the risk of HIV infection in women. Cabotegravir is being researched and developed by ViiV Healthcare, mostly owned by GlaxoSmithKline, Pfizer Inc and Shionogi Limited. The study was also sponsored by the United States National Institutes of Health (NIH), the Bill and Melinda Gates Foundation and ViiV. The study involved about 3200 women between 18 and 45 years across 7 countries in Sub-Saharan Africa which are Botswana, Kenya, Malawi, South Africa, Eswatini, Uganda and Zimbabwe.

Image of NCDC Headquarters, Abuja

Nigeria has on Friday recorded 223 confirmed new cases of the novel coronavirus, indicating an increase in cases totalling the country's cases to 63,731, while one person died, bringing the death total to 1,154, according to the Nigeria Centre for Disease Control (NCDC). The 223 cases recorded were from 17 states including Lagos (85), FCT (35), Akwa Ibom (24), Enugu (18), Plateau (13), Rivers (10), Abia (7), Ebonyi (6), Anambra (5), Adamawa (4), Bauchi (3), Imo (3), Ogun (3), Oyo (3), Kwara (2), Osun (1), Taraba (1).

COVID-19: Nigeria Records 304 New Cases, Lowest In 8 Weeks

Nigeria in eight weeks has on Sunday recorded its first lowest record of confirmed COVID-19 new cases with 304, bringing the country's total to 43,841 cases, the Nigeria Centre for Disease Control (NCDC) disclosed.

Russia Successfully Completes 1st COVID-19 Vaccine Trial

The Sechenov First Moscow State Medical University in Russian has successfully completed the World's first clinical trials for the COVID-19 vaccine on humans. The Director of the Institute for Translational Medicine and Biotechnology, Vadim Tarasov said the vaccine was produced by Gamalei Institute of Epidemiology and Microbiology on June 18, 2020.

The World Health Organisation (WHO) has ensured countries that the organisation will make COVID-19 vaccine accessible once a proven vaccine is developed and available. The Director-General, WHO, Tedros Ghebreyesus made this assertion while addressing the committee during a virtual session of the 70th WHO Regional Committee for Africa. "Our continent is facing a health crisis unlike any we have faced before. Yesterday, we crossed 1 million reported cases in the region, with more than 20,000 deaths. The number of cases has doubled just in the past 6 weeks,"

More Articles ...